An accomplished and senior life science’s professional advisor with over 30 years’ experience deploying significant expertise in taking early-stage companies forward through to commercial maturity.
Appointed to numerous Chairman, Board and CEO positions in start-up companies through to NASDAQ listings. Provided significant commercialisation and commercial advancement contributions to the health care industry. Such contributions have included providing expert advisory to pharma, diagnostics and life sciences companies. Previous engagements include Novartis Diagnostics, EPIX Pharmaceuticals, Tyrogenex and Booz, Allen & Hamilton.
A highly experienced Board Member and Chairman and Harvard Business School Graduate with a current portfolio including non-executive and executive advisory roles with a range of professional services, Government, and private entrepreneurial organisations.
Strong cross-border, cultural stakeholder with renowned matrix experience and management skills. Recognised as a problem solver and strategic thinker. Successful negotiator and strategist. Acknowledged effective change management and team leader.